What is Alpha-Gal Syndrome?

Alpha-Gal Syndrome (AGS) is an allergic condition triggered by the bite of a Lone Star tick. It causes allergic reactions to galactose-alpha-1,3-galactose (alpha-gal), a sugar molecule found in most mammals. Symptoms typically appear 3-6 hours after eating red meat, pork, or lamb, and can range from hives to life-threatening anaphylaxis. According to the CDC, over 450,000 Americans may have developed AGS since 2010.

What foods should Alpha-Gal patients avoid?

Alpha-Gal patients must avoid all mammalian meat including beef, pork, lamb, venison, and bison. Many also react to mammalian by-products like gelatin (found in gummy vitamins and gel capsules), dairy products, and ingredients derived from mammals such as lard, tallow, and carrageenan. Safe alternatives include poultry (chicken, turkey, duck), fish, seafood, eggs, and all plant-based foods.

What medications are safe for Alpha-Gal Syndrome?

Many medications contain hidden mammalian ingredients. Gel capsules and softgels often contain bovine or porcine gelatin. Safe alternatives include tablets, caplets, liquids, and capsules made with vegetable-based HPMC. Always check inactive ingredients for gelatin, magnesium stearate (usually plant-derived in US), lactose, and stearic acid. VectorShield helps patients identify safe medication alternatives.

What are the 4 sensitivity levels of Alpha-Gal Syndrome?

Alpha-Gal sensitivity varies by patient: Level 1 (Mild, ~40%) - react only to mammalian meat; Level 2 (Moderate, ~30%) - also react to gelatin products; Level 3 (Significant, ~20%) - also react to dairy products; Level 4 (Severe, ~10%) - react to trace amounts and cross-contamination, sometimes called 'super reactors'. Sensitivity can change over time, especially with additional tick bites.

Can Alpha-Gal Syndrome be cured?

There is currently no cure for Alpha-Gal Syndrome, but many patients see improvement over time if they avoid additional tick bites. Some patients report tolerance returning after 1-5 years of strict avoidance and no new tick exposures. However, a single new tick bite can restart or worsen the condition. Management focuses on strict avoidance of trigger foods and carrying emergency medication like epinephrine.

CDC sourceContent informed by CDC Alpha-Gal Syndrome resourcesView CDC resources

Research & news

Alpha-Gal Research

Stay updated on the latest scientific developments, CDC updates, and research publications about Alpha-Gal Syndrome. Everything below links straight to the primary source — peer-reviewed journals, CDC pages, and clinical trial registries.

Start with the basics of AGS

A wooded trail where Lone Star tick exposure, the focus of much AGS research, is common

450,000+

Estimated US cases (CDC)

2008

Cetuximab link discovered

2009

Delayed anaphylaxis characterized

Foundational publications cited

Recent developments

News & updates

Key milestones in how the medical community understands and reports on Alpha-Gal Syndrome.

Last reviewed: March 2026

2023-07

CDC Releases First National AGS Prevalence Estimates

New data suggests up to 450,000 Americans may be affected by Alpha-Gal Syndrome.

Source: CDC MMWR

2023-07

Geographic Distribution of Alpha-Gal Cases Mapped

Study shows AGS cases concentrated in South, East, and Central US states where Lone Star ticks are prevalent.

Source: CDC MMWR

2023

Free CDC Training Course Launched

CDC TRAIN offers free CME/CE course for healthcare providers on diagnosing and managing AGS.

Source: CDC TRAIN

The evidence base

Key publications

Foundational and recent peer-reviewed research on Alpha-Gal Syndrome. Each card links to the full record on PubMed.

2023

The evolving story of alpha-gal syndrome

Platts-Mills TAE, Commins SP, Biedermann T, et al.

Comprehensive review of AGS pathophysiology, epidemiology, and clinical management strategies.

J Allergy Clin ImmunolPubMed: 37116679

2023

Alpha-gal syndrome: An emerging cause of food allergy in the United States

Thompson JM, Carpenter A, Kersh GJ, et al.

CDC report on geographic distribution and estimated prevalence of AGS in the United States.

MMWR Morb Mortal Wkly RepPubMed: 37498790

2009

Galactose-alpha-1,3-galactose-specific IgE is associated with anaphylaxis but not asthma

Commins SP, Satinover SM, Hosen J, et al.

Landmark study establishing the link between alpha-gal IgE and delayed anaphylaxis to red meat.

Am J Respir Crit Care MedPubMed: 19286626

2009

Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose

Commins SP, Platts-Mills TA

Original characterization of AGS clinical presentation and diagnostic approach.

J Allergy Clin ImmunolPubMed: 19070355

2011

Tick bites and red meat allergy

Commins SP, James HR, Kelly LA, et al.

Establishing the causal link between tick bites and development of alpha-gal sensitivity.

Curr Opin Allergy Clin ImmunolPubMed: 21772139

2008

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose

Chung CH, Mirakhur B, Chan E, et al.

Initial discovery linking alpha-gal IgE to severe reactions to cetuximab in cancer patients.

N Engl J MedPubMed: 18322263

Search PubMed for more

In progress

Active clinical trials

Researchers are actively studying new diagnostic tools, treatments, and desensitization approaches for AGS. Browse the public registry to see what is currently enrolling and where.

Browse AGS trials Recruiting only

From the registry

ClinicalTrials.gov is the authoritative public record of AGS studies — including eligibility criteria, locations, and contact details.

Talk to your allergist before joining any study. VectorShield does not run trials and is not a substitute for medical advice.

Where to dig

Research areas

Pre-built PubMed searches grouped by topic, so you can jump straight to the literature that matters to you.

Epidemiology

Geographic distribution, prevalence estimates, and demographic patterns

alpha-gal prevalence alpha-gal epidemiology lone star tick distribution

Pathophysiology

Mechanisms of sensitization, IgE response, and delayed reaction pathways

alpha-gal mechanism alpha-gal IgE tick saliva alpha-gal

Diagnosis

Testing methods, sensitivity/specificity, and diagnostic algorithms

alpha-gal diagnosis alpha-gal sIgE test alpha-gal skin prick

Treatment

Management strategies, immunotherapy research, and prognosis studies

alpha-gal treatment alpha-gal immunotherapy alpha-gal desensitization

Official guidance

CDC resources

We monitor these official CDC pages for updates. Content on this site reflects the latest CDC guidance as of our last sync.

Alpha-Gal Syndrome Home About AGS Signs & Symptoms Managing AGS Clinical Diagnosis & Testing Provider Training Products Containing Alpha-Gal

Reading ingredient labels at the grocery store, a daily reality informed by AGS research

CDC's "Products Containing Alpha-Gal" page is one of the most practical references for label reading — the same daily task VectorShield is built to make easier.

Collaborate

Are you a researcher?

If you are conducting research on Alpha-Gal Syndrome and would like your work featured here, or if you have corrections to existing content, please reach out.

Open to corrections

We hold this page to a primary-source standard. If something here is out of date or inaccurate, tell us and we will fix it.